Clinical Trials Directory

Trials / Completed

CompletedNCT01828047

Sublingual Microcirculation and Postoperative Ileus

Correlation Between Sublingual Microcirculation and Postoperative Ileus Symptoms in Patients Undergoing Colorectal Surgery - a Pilot Study

Status
Completed
Phase
Study type
Observational
Enrollment
34 (actual)
Sponsor
Gabriele Baldini, MD, MSc, Assistant Professor · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of this pilot study is to establish if a correlation between sub-lingual microcirculation measured by Orthogonal polarization spectral (OPS) imaging and symptoms of postoperative ileus exist in patients undergoing elective colorectal surgery.

Detailed description

AIM OF THE STUDY This observational study will assess whether perioperative microcirculatory changes can be correlated with symptoms associated with primary POI. PRIMARY RESEARCH QUESTION Is there a correlation between peri-operative microcirculatory flow measurements and the incidence of symptomatic primary POI? SECONDARY RESEARCH QUESTIONS 1. Is there a correlation between peri-operative microcirculatory flow measurements and the duration of symptomatic primary POI? 2. If any correlation is observed, which anatomic location (sublingual mucosa vs bowel serosa) yields microcirculatory flow measurements that are more strongly associated with the incidence and/or duration of symptomatic primary POI? 3. Can either intraoperative sublingual mucosa or intraoperative bowel serosa microcirculatory flow measurements predict symptoms of primary POI? Are these two anatomic locations equivalent in their ability to predict this complication?

Conditions

Interventions

TypeNameDescription
DEVICEorthogonal polarization spectral (OPS) imagingorthogonal polarization spectral (OPS) imaging allows noninvasive observation of human microcirculation in all accessible tissue surfaces

Timeline

Start date
2013-11-01
Primary completion
2014-11-01
Completion
2014-11-01
First posted
2013-04-10
Last updated
2015-03-17

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01828047. Inclusion in this directory is not an endorsement.